News

Eli Lilly will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying customers on its website starting early August, the U.S. drugmaker said on Monday.
(Reuters) -U.S. drugmaker Eli Lilly said on Monday it will offer the higher-dose versions of its popular weight-loss drug Zepbound on its website LillyDirect, with shipments starting in early August.
Drugmaker Eli Lilly announced on Thursday a new website that will allow patients to get a weight loss drug prescription through a telehealth provider — a move, the company says, that will ...
Eli Lilly and Company LLY is launching a new direct-to-consumer website called LillyDirect, ... GLP-1 drugs work by mimicking the hormone GLP-1, resulting in weight loss, ...
Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...
Eli Lilly (LLY), the maker of the blockbuster weight-loss drug Zepbound, launched a new advertising campaign on Friday warning patients about off-brand versions of its treatments, saying “they ...
Jan 4 (Reuters) - Eli Lilly and Co LLY.N on Thursday launched a website to help people with obesity get prescriptions through telehealth providers and provide home delivery of its weight-loss ...
In January, Eli Lilly & Co. launched its LillyDirect portal to sell popular obesity and diabetes treatments, marking the first time a major drug company hawked products straight to consumers.
(Reuters) -Eli Lilly will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying customers on its website starting early August, the U.S. drugmaker said on Monday.
Struggling with plunging demand for its Covid products, Pfizer Inc. has a new plan to reach potential customers: Using telehealth to sell drugs straight to patients. The company launched a website ...